Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese population.

@article{Iwamoto2009PredictionOD,
  title={Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese population.},
  author={Naoki Iwamoto and Atsushi Kawakami and Keita Fujikawa and Toshiyuki Aramaki and Shin-ya Kawashiri and Mami Tamai and Kazuhiko Arima and Kunihiro Ichinose and Makoto Kamachi and Satoshi Yamasaki and Hideki Nakamura and Munetoshi Nakashima and Akinari Mizokami and Akiko S Goto and Toshiro Fukuda and Naoki Matsuoka and Yukitaka Ueki and Toshiaki Tsukada and Kiyoshi Migita and Fumiko Shoumura and Yojiro Kawabe and Kazutaka Shibatomi and Masanobu Mine and Hiroaki Ida and Tomoki Origuchi and Kiyoshi Aoyagi and Katsumi Eguchi},
  journal={Modern rheumatology},
  year={2009},
  volume={19 5},
  pages={488-92}
}
We tried to determine which baseline variables are responsible for remission induction at 6 months in unselected rheumatoid arthritis (RA) patients of Japanese population treated with etanercept. One hundred forty-one patients with RA who were administered etanercept were registered. Thirty-four patients were started on etanercept monotherapy, 60 patients on cotherapy with methotrexate (MTX) (MTX cotherapy), and 47 patients on cotherapy with other non-MTX nonbiologic disease-modifying… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.
Showing 1-8 of 8 references

Similar Papers

Loading similar papers…